Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuphoria Therapeutics (NEUP) Short-term Investments (2024 - 2025)

Historic Short-term Investments for Neuphoria Therapeutics (NEUP) over the last 2 years, with Q4 2025 value amounting to $79647.0.

  • Neuphoria Therapeutics' Short-term Investments rose 765.73% to $79647.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $79647.0, marking a year-over-year increase of 765.73%. This contributed to the annual value of $77945.0 for FY2025, which is N/A changed from last year.
  • Neuphoria Therapeutics' Short-term Investments amounted to $79647.0 in Q4 2025, which was up 765.73% from $78564.0 recorded in Q3 2025.
  • In the past 5 years, Neuphoria Therapeutics' Short-term Investments registered a high of $79647.0 during Q4 2025, and its lowest value of $73982.0 during Q4 2024.